Drug-Coated Balloon-Only Percutaneous Coronary Intervention for the Treatment of De Novo Coronary Artery Disease: A Systematic Review
Abstract Percutaneous coronary intervention (PCI) with a drug coated balloon (DCB) is a novel treatment which seeks to acutely dilate a coronary stenosis and deliver an anti-proliferative drug to the vessel wall (reducing the risk of re-stenosis), without implanting a drug eluting stent (DES). In th...
Main Authors: | Hasan Mohiaddin, Tamar D. F. K. Wong, Anne Burke-Gaffney, Richard G. Bogle |
---|---|
Format: | Article |
Language: | English |
Published: |
Adis, Springer Healthcare
2018-10-01
|
Series: | Cardiology and Therapy |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1007/s40119-018-0121-2 |
Similar Items
-
Technical success, clinical efficacy, and insight into the causes of restenosis after the percutaneous coronary intervention of de novo coronary artery lesions using a paclitaxel-coated balloon with citrate ester excipient
by: Jerry Tervo, et al.
Published: (2022-10-01) -
Long-Term Clinical Outcomes After Percutaneous Coronary Intervention With Drug-Coated Balloon-Only Strategy in de novo Lesions of Large Coronary Arteries
by: Feng-Wang Hu, et al.
Published: (2022-07-01) -
Short Term Outcome of Drug Eluting Balloon for Percutaneous Coronary Intervention
by: Maida Anwar, et al.
Published: (2023-12-01) -
Coronary artery aneurysm formation after paclitaxel-coated balloon-only intervention for de novo coronary chronic total occlusion
by: Eun Jung Jun, et al.
Published: (2023-01-01) -
Efficacy of Drug-Coated Balloon Approaches for de novo Coronary Artery Diseases: A Bayesian Network Meta-Analysis
by: Peng-Yu Zhong, et al.
Published: (2022-06-01)